Tag: Cancer: Ovarian

43.2 percent missed opportunity rate reported for germline genetic testing, risk-reducing surgery in those with affected first-degree relative

Model includes age, body mass index, hypertriglyceridemia, tumor staging, tumor grade, CA125 level, platelet count, fibrinogen level

Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients

Greater parity and ever use of contraception associated with lower risk for ovarian cancer

Implementing opportunistic salpingectomy would lead to health care cost savings

Transformer-based neural network models surpass diagnostic performance of examiners for identifying ovarian cancer in ultrasound images

Sensitivity higher, but some loss seen in specificity, when compared with Risk of Malignancy 1 index at threshold of 250

Ovarian cancer detected with specificity >99 percent and sensitivity ranging from 69 to 100 percent depending on stage

Among those with high-grade serous ovarian cancer, 25.2 percent of women were diagnosed with stages I/II